Cardiac amyloidosis: The great masquerader

Authors

  • Jubran Rind Michigan State University School of Human Medicine
  • Nagib Chalfoun Michigan State University School of Human Medicine
  • Richard McNamara Spectrum Health Frederik Meijer Heart & Vascular Institute

DOI:

https://doi.org/10.21542/gcsp.2018.18

Abstract

Cardiac amyloidosis is an elusive condition that is notorious for mimicking various cardiovascular conditions that present with left ventricular hypertrophy (LVH). The hypertrophy in amyloidosis is typically diffuse; however, rare reports of echocardiographic resemblances with hypertrophic cardiomyopathy (HCM) exist, such as asymmetric septal hypertrophy and left ventricular outflow tract obstruction. Cardiac MRI can help differentiate amyloidosis from hypertrophic cardiomyopathy in unclear situations. This differentiation from HCM and other forms of cardiomyopathy has important treatment implications. Here we present the case of a 76-year-old man with cardiomyopathy who had echocardiographic features of asymmetric hypertrophic cardiomyopathy but was correctly diagnosed with amyloidosis with the help of cardiac MRI and ECG.

Downloads

Published

2018-07-23

Issue

Section

Images in cardiology